PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1916509
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1916509
Veterinary Therapeutics Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
Growth Factors of veterinary therapeutics Market
The global veterinary therapeutics market size was valued at USD 47.25 billion in 2025 and is projected to grow to USD 49.65 billion in 2026, reaching USD 81.59 billion by 2034, registering a CAGR of 6.40% during the forecast period (2026-2034). North America dominated the global veterinary therapeutics market with a 40.02% market share in 2025, supported by high pet ownership rates, strong veterinary healthcare infrastructure, and advanced livestock farming practices.
Veterinary therapeutics includes drugs, vaccines, and medicated feed additives used for disease prevention, treatment, and productivity improvement in both companion and livestock animals. The market plays a critical role in controlling zoonotic diseases, maintaining food safety, and improving animal welfare.
Market Drivers
Rising pet ownership and increasing expenditure on animal health are primary drivers. In the U.S., pet ownership reached 59.8 million dogs and 42.2 million cats in 2024, with average annual household spending of USD 580 for dogs and USD 433 for cats, driving demand for preventive medicines and chronic disease treatments.
Growing livestock production to meet rising global protein demand also contributes to market expansion. According to the World Organization for Animal Health, 77.0% of global livestock is affected by foot-and-mouth disease, increasing demand for vaccines and early disease management. Rising cases of parasitic infections, bovine mastitis, canine parvovirus, and tick-borne diseases further elevate therapeutic demand.
Product launches continue to stimulate growth. In September 2024, Elanco received FDA approval for Zenrelia, a once-daily oral treatment for allergic dermatitis in dogs, reflecting increasing innovation in companion animal therapeutics.
Market Restraints
Product recalls due to adverse reactions and safety issues reduce consumer confidence. In June 2021, the U.K. Veterinary Medicines Directorate recalled Salmovac 400 vaccine produced by CEVA due to safety concerns. In December 2023, Australia recalled Triedlia Auslepto vaccine for dogs after reports of severe adverse reactions, including fatality. Such incidents impact brand reputation and regulatory scrutiny, restraining market growth.
Market Opportunities
R&D investment and regulatory approvals are generating growth opportunities. In April 2024, the FDA approved Pradalex injection for treating bovine and swine respiratory diseases, expanding livestock disease management options. Increased focus on advanced biologics and targeted therapies supports disease control with improved safety profiles.
Growing awareness among farmers and pet owners regarding preventive healthcare also increases adoption of vaccination programs and early diagnostics, expanding market potential across emerging economies.
Market Challenges
Antimicrobial resistance (AMR) presents a major challenge, particularly in low-income agricultural regions where antibiotic misuse is common. In September 2024, the World Organization for Animal Health estimated that antimicrobial resistance could increase global healthcare costs by USD 189.0 billion by 2025. Stricter antimicrobial regulations limit drug availability and affect livestock productivity, challenging therapeutic market growth.
Market Trends
Gene and cell therapies are emerging as innovative treatment approaches in veterinary medicine. In December 2024, Protect Animal Health partnered with Rejuvenate Bio to develop gene therapy PT-401 for treating mitral valve disease in dogs, indicating a shift toward personalized veterinary medicine.
Telemedicine adoption during COVID-19 also increased prescription access and monitoring of chronic conditions, further supporting therapeutic sales.
Segmentation Analysis
By Product
Veterinary drugs dominated with 64.87% share in 2026, driven by high disease prevalence and generic drug approvals. FDA approval of phenylpropanolamine chewable tablets in June 2024 for canine urinary incontinence further strengthened drug sales. Vaccines remain essential for infectious disease control, with new BRD vaccines under development. Medicated feed additives grow steadily to improve livestock productivity and feed efficiency.
By Animal Type
Companion animals accounted for 46.1% share in 2025, supported by rising pet ownership and preventive healthcare spending. Livestock dominated in 2026 due to increased protein demand and disease prevention programs, growing at 5.42% CAGR during 2025-2032.
By Route of Administration
Parenteral routes dominated in 2024 due to vaccine delivery and emergency treatments, supported by government vaccination programs. Oral therapeutics are expected to reach 47.23% share in 2026, driven by products such as Zenrelia tablets. Topical formulations grow due to rising dermatological conditions, while aerosol therapies expand moderately.
By Distribution Channel
Veterinary clinics dominated due to frequent pet checkups and outpatient services, growing at 6.14% CAGR during 2025-2032. Veterinary hospitals are expected to reach 40.99% share in 2026, supported by advanced diagnostic collaborations. Pharmacies grow through improved accessibility and in-clinic dispensing services.
Regional Outlook
North America generated USD 18.91 billion in 2025 and USD 20.10 billion in 2026, led by the U.S. reaching USD 18.93 billion in 2026. Europe reached USD 12.01 billion with strong government welfare programs and manufacturing capabilities. Asia Pacific is projected at USD 8.80 billion in 2026, driven by China (USD 1.53 billion), India (USD 1.57 billion), and Japan (USD 3.30 billion). Latin America reached USD 5.02 billion in 2025, while GCC markets reached USD 1.50 billion in 2025, supported by pharmacovigilance reforms and disease control programs.
Competitive Landscape
Major players including Zoetis, Merck Animal Health, Elanco, Boehringer Ingelheim, Ceva, Vetoquinol, and Virbac lead through product approvals and global expansion. Strategic acquisitions such as Phibro's acquisition of Zoetis' feed additive portfolio in April 2024 strengthen portfolio breadth. Continuous innovation and sustainability initiatives remain central to competitive strategies.
Report Coverage
The veterinary therapeutics market report provides a comprehensive analysis of the global industry with a detailed evaluation of market size and value for 2025, 2026, and 2034, along with the forecast growth trajectory at a CAGR of 6.40% during 2026-2034. The report examines key product categories including veterinary drugs, veterinary vaccines, and medicated feed additives, and evaluates their adoption across companion animals and livestock. It further analyzes the market by route of administration (oral, parenteral, topical, and aerosol) and distribution channels such as veterinary clinics, veterinary hospitals, pharmacies & drug stores, and others.
The study includes an in-depth assessment of market drivers, restraints, opportunities, challenges, and emerging trends, highlighting the impact of rising pet ownership, livestock disease burden, antimicrobial resistance, and the emergence of gene and cell therapies. Regional analysis covers North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa, with country-level insights for major markets including the U.S., U.K., Germany, France, China, India, and Japan, using verified market value data for 2025 and 2026. The report also profiles leading companies such as Zoetis, Merck Animal Health, Elanco, Boehringer Ingelheim, Ceva, Virbac, and Vetoquinol, and tracks recent product approvals, acquisitions, collaborations, and logistics expansions that influence competitive positioning. Additionally, the report evaluates the impact of COVID-19, regulatory trends, pharmacovigilance systems, and sustainability initiatives shaping long-term industry development.
Conclusion
The global veterinary therapeutics market is expanding steadily from USD 47.25 billion in 2025 to USD 49.65 billion in 2026, and is projected to reach USD 81.59 billion by 2034, supported by rising pet ownership, increasing livestock production, and heightened focus on zoonotic disease control and food safety. North America dominated with 40.02% market share in 2025, driven by high pet healthcare spending, strong veterinary infrastructure, and advanced farming technologies, while Asia Pacific and Latin America are gaining momentum due to expanding livestock sectors and improving veterinary access.
Product-wise, veterinary drugs dominate with 64.87% share in 2026, reflecting high treatment demand for infectious, parasitic, and chronic animal diseases, while vaccines remain critical for outbreak prevention and feed additives support productivity in commercial farming. Companion animals accounted for 46.1% share in 2025, but livestock leads in 2026 due to rising global protein consumption and stricter biosecurity practices. Although challenges such as antimicrobial resistance, product recalls, and regulatory tightening continue to affect adoption patterns, strong R&D pipelines, growing approvals for targeted biologics, and the emergence of gene and cell therapies are reshaping future treatment paradigms. Overall, sustained innovation, preventive healthcare adoption, and expanding veterinary infrastructure are expected to keep veterinary therapeutics a vital and growing segment of global animal health.
Segmentation By Product
- Veterinary Drugs
- Anti-infectives
- Anti-inflammatory
- Parasiticides
- Others
- Veterinary Vaccines
- Inactivated
- Live Attenuated
- Recombinant
- Others
- Medicated Feed Additives
- Antimicrobials
- Anticoccidials
- Antiparasitics
- Others
By Route of Administration
- Oral
- Parenteral
- Topical
- Aerosol
By Distribution Channel
- Veterinary Hospitals
- Veterinary Clinics
- Pharmacies & Drug Stores
- Others
By Region
- North America (By Product, By Animal Type, Route of Administration, Distribution Channel, and Country)
- U.S.
- Canada
- Europe (By Product, By Animal Type, Route of Administration, Distribution Channel, and Country/Sub-Region)
- U.K.
- Germany
- France
- Spain
- Italy
- Scandinavia
- Rest of Europe
- Asia Pacific (By Product, By Animal Type, By Route of Administration, By Distribution Channel, and Country/Sub-Region)
- Japan
- China
- India
- Australia
- Southeast Asia
- Rest of Asia Pacific
- Latin America (By Product, Animal Type, Route of Administration, Distribution Channel, and Country/Sub-Region)
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa (By Product, Animal Type, Route of Administration, Distribution Channel, and Country/Sub-Region)
- GCC
- South Africa
- Rest of the Middle East & Africa
Table of Content
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Trends
4. Key Insights
- 4.1. Overview of Animal Diseases by Key Countries, By Key Countries/ Region, 2025
- 4.2. Pipeline Analysis
- 4.3. Regulatory Scenario By Key Countries/ Region, 2025
- 4.4. Pricing Analysis
- 4.5. Pet Ownership Statistics, By Key Countries/ Region, 2025
- 4.6. Snapshot on the Novel & Upcoming Therapies
- 4.7. Overview of Treatment Plans for Different Animal Diseases
- 4.8. New Product Launches, By Key Players
- 4.9. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
- 4.10. Impact of COVID-19 on the Global Veterinary Therapeutics Market
5. Global Veterinary Therapeutics Market Analysis, Insights and Forecast, 2021-2034
- 5.1. Market Analysis, Insights and Forecast - By Product
- 5.1.1. Veterinary Drugs
- 5.1.1.1. Anti-infectives
- 5.1.1.2. Anti-inflammatory
- 5.1.1.3. Parasiticides
- 5.1.1.4. Others
- 5.1.2. Veterinary Vaccines
- 5.1.2.1. Inactivated
- 5.1.2.2. Live Attenuated
- 5.1.2.3. Recombinant
- 5.1.2.4. Others
- 5.1.3. Medicated Feed Additives
- 5.1.3.1. Antimicrobials
- 5.1.3.2. Anti-coccidials
- 5.1.3.3. Antiparasitics
- 5.1.3.4. Others
- 5.1.1. Veterinary Drugs
- 5.2. Market Analysis, Insights and Forecast - By Animal Type
- 5.2.1. Companion
- 5.2.1.1. Feline
- 5.2.1.2. Canine
- 5.2.1.3. Avian
- 5.2.1.4. Others
- 5.2.2. Livestock
- 5.2.2.1. Poultry
- 5.2.2.2. Porcine
- 5.2.2.3. Bovine
- 5.2.2.4. Others
- 5.2.1. Companion
- 5.3. Market Analysis, Insights and Forecast - By Route of Administration
- 5.3.1. Oral
- 5.3.2. Parenteral
- 5.3.3. Topical
- 5.3.4. Aerosol
- 5.4. Market Analysis, Insights and Forecast - By Distribution Channel
- 5.4.1. Veterinary Hospitals
- 5.4.2. Veterinary Clinics
- 5.4.3. Pharmacies & Drug Stores
- 5.4.4. Others
- 5.5. Market Analysis, Insights and Forecast - Region
- 5.5.1. North America
- 5.5.2. Europe
- 5.5.3. Asia Pacific
- 5.5.4. Latin America
- 5.5.5. Middle East & Africa
6. North America Veterinary Therapeutics Market Analysis, Insights and Forecast, 2021-2034
- 6.1. Market Analysis, Insights and Forecast - By Product
- 6.1.1. Veterinary Drugs
- 6.1.1.1. Anti-infectives
- 6.1.1.2. Anti-inflammatory
- 6.1.1.3. Parasiticides
- 6.1.1.4. Others
- 6.1.2. Veterinary Vaccines
- 6.1.2.1. Inactivated
- 6.1.2.2. Live Attenuated
- 6.1.2.3. Recombinant
- 6.1.2.4. Others
- 6.1.3. Medicated Feed Additives
- 6.1.3.1. Antimicrobials
- 6.1.3.2. Anti-coccidials
- 6.1.3.3. Antiparasitics
- 6.1.3.4. Others
- 6.1.1. Veterinary Drugs
- 6.2. Market Analysis, Insights and Forecast - By Animal Type
- 6.2.1. Companion
- 6.2.1.1. Feline
- 6.2.1.2. Canine
- 6.2.1.3. Avian
- 6.2.1.4. Others
- 6.2.2. Livestock
- 6.2.2.1. Poultry
- 6.2.2.2. Porcine
- 6.2.2.3. Bovine
- 6.2.2.4. Others
- 6.2.1. Companion
- 6.3. Market Analysis, Insights and Forecast - By Route of Administration
- 6.3.1. Oral
- 6.3.2. Parenteral
- 6.3.3. Topical
- 6.3.4. Aerosol
- 6.4. Market Analysis, Insights and Forecast - By Distribution Channel
- 6.4.1. Veterinary Hospitals
- 6.4.2. Veterinary Clinics
- 6.4.3. Pharmacies & Drug Stores
- 6.4.4. Others
- 6.5. Market Analysis, Insights and Forecast - By Country
- 6.5.1. U.S.
- 6.5.2. Canada
7. Europe Veterinary Therapeutics Market Analysis, Insights and Forecast, 2021-2034
- 7.1. Market Analysis, Insights and Forecast - By Product
- 7.1.1. Veterinary Drugs
- 7.1.1.1. Anti-infectives
- 7.1.1.2. Anti-inflammatory
- 7.1.1.3. Parasiticides
- 7.1.1.4. Others
- 7.1.2. Veterinary Vaccines
- 7.1.2.1. Inactivated
- 7.1.2.2. Live Attenuated
- 7.1.2.3. Recombinant
- 7.1.2.4. Others
- 7.1.3. Medicated Feed Additives
- 7.1.3.1. Antimicrobials
- 7.1.3.2. Anti-coccidials
- 7.1.3.3. Antiparasitics
- 7.1.3.4. Others
- 7.1.1. Veterinary Drugs
- 7.2. Market Analysis, Insights and Forecast - By Animal Type
- 7.2.1. Companion
- 7.2.1.1. Feline
- 7.2.1.2. Canine
- 7.2.1.3. Avian
- 7.2.1.4. Others
- 7.2.2. Livestock
- 7.2.2.1. Poultry
- 7.2.2.2. Porcine
- 7.2.2.3. Bovine
- 7.2.2.4. Others
- 7.2.1. Companion
- 7.3. Market Analysis, Insights and Forecast - By Route of Administration
- 7.3.1. Oral
- 7.3.2. Parenteral
- 7.3.3. Topical
- 7.3.4. Aerosol
- 7.4. Market Analysis, Insights and Forecast - By Distribution Channel
- 7.4.1. Veterinary Hospitals
- 7.4.2. Veterinary Clinics
- 7.4.3. Pharmacies & Drug Stores
- 7.4.4. Others
- 7.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
- 7.5.1. Germany
- 7.5.2. U.K.
- 7.5.3. France
- 7.5.4. Italy
- 7.5.5. Spain
- 7.5.6. Scandinavia
- 7.5.7. Rest of Europe
8. Asia Pacific Veterinary Therapeutics Market Analysis, Insights and Forecast, 2021-2034
- 8.1. Market Analysis, Insights and Forecast - By Product
- 8.1.1. Veterinary Drugs
- 8.1.1.1. Anti-infectives
- 8.1.1.2. Anti-inflammatory
- 8.1.1.3. Parasiticides
- 8.1.1.4. Others
- 8.1.2. Veterinary Vaccines
- 8.1.2.1. Inactivated
- 8.1.2.2. Live Attenuated
- 8.1.2.3. Recombinant
- 8.1.2.4. Others
- 8.1.3. Medicated Feed Additives
- 8.1.3.1. Antimicrobials
- 8.1.3.2. Anti-coccidials
- 8.1.3.3. Antiparasitics
- 8.1.3.4. Others
- 8.1.1. Veterinary Drugs
- 8.2. Market Analysis, Insights and Forecast - By Animal Type
- 8.2.1. Companion
- 8.2.1.1. Feline
- 8.2.1.2. Canine
- 8.2.1.3. Avian
- 8.2.1.4. Others
- 8.2.2. Livestock
- 8.2.2.1. Poultry
- 8.2.2.2. Porcine
- 8.2.2.3. Bovine
- 8.2.2.4. Others
- 8.2.1. Companion
- 8.3. Market Analysis, Insights and Forecast - By Route of Administration
- 8.3.1. Oral
- 8.3.2. Parenteral
- 8.3.3. Topical
- 8.3.4. Aerosol
- 8.4. Market Analysis, Insights and Forecast - By Distribution Channel
- 8.4.1. Veterinary Hospitals
- 8.4.2. Veterinary Clinics
- 8.4.3. Pharmacies & Drug Stores
- 8.4.4. Others
- 8.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
- 8.5.1. China
- 8.5.2. Japan
- 8.5.3. India
- 8.5.4. Australia
- 8.5.5. Southeast Asia
- 8.5.6. Rest of Asia Pacific
9. Latin America Veterinary Therapeutics Market Analysis, Insights and Forecast, 2021-2034
- 9.1. Market Analysis, Insights and Forecast - By Product
- 9.1.1. Veterinary Drugs
- 9.1.1.1. Anti-infectives
- 9.1.1.2. Anti-inflammatory
- 9.1.1.3. Parasiticides
- 9.1.1.4. Others
- 9.1.2. Veterinary Vaccines
- 9.1.2.1. Inactivated
- 9.1.2.2. Live Attenuated
- 9.1.2.3. Recombinant
- 9.1.2.4. Others
- 9.1.3. Medicated Feed Additives
- 9.1.3.1. Antimicrobials
- 9.1.3.2. Anti-coccidials
- 9.1.3.3. Antiparasitics
- 9.1.3.4. Others
- 9.1.1. Veterinary Drugs
- 9.2. Market Analysis, Insights and Forecast - By Animal Type
- 9.2.1. Companion
- 9.2.1.1. Feline
- 9.2.1.2. Canine
- 9.2.1.3. Avian
- 9.2.1.4. Others
- 9.2.2. Livestock
- 9.2.2.1. Poultry
- 9.2.2.2. Porcine
- 9.2.2.3. Bovine
- 9.2.2.4. Others
- 9.2.1. Companion
- 9.3. Market Analysis, Insights and Forecast - By Route of Administration
- 9.3.1. Oral
- 9.3.2. Parenteral
- 9.3.3. Topical
- 9.3.4. Aerosol
- 9.4. Market Analysis, Insights and Forecast - By Distribution Channel
- 9.4.1. Veterinary Hospitals
- 9.4.2. Veterinary Clinics
- 9.4.3. Pharmacies & Drug Stores
- 9.4.4. Others
- 9.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
- 9.5.1. Brazil
- 9.5.2. Mexico
- 9.5.3. Rest of Latin America
10. Middle East & Africa Veterinary Therapeutics Market Analysis, Insights and Forecast, 2021-2034
- 10.1. Market Analysis, Insights and Forecast - By Product
- 10.1.1. Veterinary Drugs
- 10.1.1.1. Anti-infectives
- 10.1.1.2. Anti-inflammatory
- 10.1.1.3. Parasiticides
- 10.1.1.4. Others
- 10.1.2. Veterinary Vaccines
- 10.1.2.1. Inactivated
- 10.1.2.2. Live Attenuated
- 10.1.2.3. Recombinant
- 10.1.2.4. Others
- 10.1.3. Medicated Feed Additives
- 10.1.3.1. Antimicrobials
- 10.1.3.2. Anti-coccidials
- 10.1.3.3. Antiparasitics
- 10.1.3.4. Others
- 10.1.1. Veterinary Drugs
- 10.2. Market Analysis, Insights and Forecast - By Animal Type
- 10.2.1. Companion
- 10.2.1.1. Feline
- 10.2.1.2. Canine
- 10.2.1.3. Avian
- 10.2.1.4. Others
- 10.2.2. Livestock
- 10.2.2.1. Poultry
- 10.2.2.2. Porcine
- 10.2.2.3. Bovine
- 10.2.2.4. Others
- 10.2.1. Companion
- 10.3. Market Analysis, Insights and Forecast - By Route of Administration
- 10.3.1. Oral
- 10.3.2. Parenteral
- 10.3.3. Topical
- 10.3.4. Aerosol
- 10.4. Market Analysis, Insights and Forecast - By Distribution Channel
- 10.4.1. Veterinary Hospitals
- 10.4.2. Veterinary Clinics
- 10.4.3. Pharmacies & Drug Stores
- 10.4.4. Others
- 10.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
- 10.5.1. GCC
- 10.5.2. South Africa
- 10.5.3. Rest of Middle East & Africa
11. Competitive Analysis
- 11.1. Global Market Share Analysis (2025)
- 11.2. Company Profiles
- 11.2.1. Zoetis Services LLC
- 11.2.1.1. Overview
- 11.2.1.2. Products
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Strategies
- 11.2.1.6. Financials (Based on Availability)
- 11.2.2. Merck Animal Health
- 11.2.2.1. Overview
- 11.2.2.2. Products
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Strategies
- 11.2.2.6. Financials (Based on Availability)
- 11.2.3. Elanco
- 11.2.3.1. Overview
- 11.2.3.2. Products
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Strategies
- 11.2.3.6. Financials (Based on Availability)
- 11.2.4. Boehringer Ingelheim International GmbH.
- 11.2.4.1. Overview
- 11.2.4.2. Products
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Strategies
- 11.2.4.6. Financials (Based on Availability)
- 11.2.5. Ceva
- 11.2.5.1. Overview
- 11.2.5.2. Products
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Strategies
- 11.2.5.6. Financials (Based on Availability)
- 11.2.6. Vetoquinol
- 11.2.6.1. Overview
- 11.2.6.2. Products
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Strategies
- 11.2.6.6. Financials (Based on Availability)
- 11.2.7. Virbac
- 11.2.7.1. Overview
- 11.2.7.2. Products
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Strategies
- 11.2.7.6. Financials (Based on Availability)
- 11.2.8. Phibro Animal Health Corporation
- 11.2.8.1. Overview
- 11.2.8.2. Products
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Strategies
- 11.2.8.6. Financials (Based on Availability)
- 11.2.9. Panav Bio Tech.
- 11.2.9.1. Overview
- 11.2.9.2. Products
- 11.2.9.3. SWOT Analysis
- 11.2.9.4. Recent Developments
- 11.2.9.5. Strategies
- 11.2.9.6. Financials (Based on Availability)
- 11.2.1. Zoetis Services LLC
List of Tables
- Table 1: Global Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 2: Global Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Veterinary Drugs, 2021-2034
- Table 3: Global Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Veterinary Vaccines, 2021-2034
- Table 4: Global Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Medicated Feed Additives, 2021-2034
- Table 5: Global Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Animal Type, 2021-2034
- Table 6: Global Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Companion, 2021-2034
- Table 7: Global Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Livestock, 2021-2034
- Table 8: Global Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Route of Administration 2021-2034
- Table 9: Global Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
- Table 10: Global Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Region, 2021-2034
- Table 11: North America Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 12: North America Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Veterinary Drugs, 2021-2034
- Table 13: North America Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Veterinary Vaccines, 2021-2034
- Table 14: North America Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Medicated Feed Additives, 2021-2034
- Table 15: North America Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Animal Type, 2021-2034
- Table 16: North America Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Companion, 2021-2034
- Table 17: North America Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Livestock, 2021-2034
- Table 18: North America Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Route of Administration 2021-2034
- Table 19: North America Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
- Table 20: North America Veterinary Therapeutics Market Revenue (USD billion) Forecast, By Country, 2021-2034
- Table 21: Europe Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 22: Europe Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Veterinary Drugs, 2021-2034
- Table 23: Europe Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Veterinary Vaccines, 2021-2034
- Table 24: Europe Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Medicated Feed Additives, 2021-2034
- Table 25: Europe Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Animal Type, 2021-2034
- Table 26: Europe Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Companion, 2021-2034
- Table 27: Europe Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Livestock, 2021-2034
- Table 28: Europe Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Route of Administration 2021-2034
- Table 29: Europe Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
- Table 30: Europe Veterinary Therapeutics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
- Table 31: Asia Pacific Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 32: Asia Pacific Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Veterinary Drugs, 2021-2034
- Table 33: Asia Pacific Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Veterinary Vaccines, 2021-2034
- Table 34: Asia Pacific Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Medicated Feed Additives, 2021-2034
- Table 35: Asia Pacific Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Animal Type, 2021-2034
- Table 36: Asia Pacific Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Companion, 2021-2034
- Table 37: Asia Pacific Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Livestock, 2021-2034
- Table 38: Asia Pacific Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Route of Administration 2021-2034
- Table 39: Asia Pacific Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
- Table 40: Asia Pacific Veterinary Therapeutics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
- Table 41: Latin America Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 42: Latin America Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Veterinary Drugs, 2021-2034
- Table 43: Latin America Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Veterinary Vaccines, 2021-2034
- Table 44: Latin America Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Medicated Feed Additives, 2021-2034
- Table 45: Latin America Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Animal Type, 2021-2034
- Table 46: Latin America Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Companion, 2021-2034
- Table 47: Latin America Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Livestock, 2021-2034
- Table 48: Latin America Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Route of Administration 2021-2034
- Table 49: Latin America Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
- Table 50: Latin America Veterinary Therapeutics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
- Table 51: Middle East & Africa Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 52: Middle East & Africa Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Veterinary Drugs, 2021-2034
- Table 53: Middle East & Africa Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Veterinary Vaccines, 2021-2034
- Table 54: Middle East & Africa Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Medicated Feed Additives, 2021-2034
- Table 55: Middle East & Africa Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Animal Type, 2021-2034
- Table 56: Middle East & Africa Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Companion, 2021-2034
- Table 57: Middle East & Africa Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Livestock, 2021-2034
- Table 58: Middle East & Africa Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Route of Administration 2021-2034
- Table 59: Middle East & Africa Veterinary Therapeutics Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
- Table 60: Middle East & Africa Veterinary Therapeutics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
List of Figures
- Figure 1: Global Veterinary Therapeutics Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
- Figure 2: Global Veterinary Therapeutics Market Value Share (%), by Product, 2025 & 2034
- Figure 3: Global Veterinary Therapeutics Market Value Share (%), by Animal Type, 2025 & 2034
- Figure 4: Global Veterinary Therapeutics Market Value Share (%), by Route of Administration, 2025 & 2034
- Figure 5: Global Veterinary Therapeutics Market Value Share (%), by Distribution Channel, 2025 & 2034
- Figure 6: Global Veterinary Therapeutics Market Value (USD billion), by Region, 2025 & 2034
- Figure 7: North America Veterinary Therapeutics Market Value (USD billion), by Product, 2025 & 2034
- Figure 8: North America Veterinary Therapeutics Market Value Share (%), by Product, 2025
- Figure 9: North America Veterinary Therapeutics Market Value (USD billion), by Animal Type, 2025 & 2034
- Figure 10: North America Veterinary Therapeutics Market Value Share (%), by Animal Type, 2025
- Figure 11: North America Veterinary Therapeutics Market Value (USD billion), by Route of Administration, 2025 & 2034
- Figure 12: North America Veterinary Therapeutics Market Value Share (%), by Route of Administration, 2025
- Figure 13: North America Veterinary Therapeutics Market Value (USD billion), by Distribution Channel, 2025 & 2034
- Figure 14: North America Veterinary Therapeutics Market Value Share (%), by Distribution Channel, 2025
- Figure 15: North America Veterinary Therapeutics Market Value (USD billion), By Country, 2025 & 2034
- Figure 16: North America Veterinary Therapeutics Market Value Share (%), By Country, 2025
- Figure 17: Europe Veterinary Therapeutics Market Value (USD billion), by Product, 2025 & 2034
- Figure 18: Europe Veterinary Therapeutics Market Value Share (%), by Product, 2025
- Figure 19: Europe Veterinary Therapeutics Market Value (USD billion), by Animal Type, 2025 & 2034
- Figure 20: Europe Veterinary Therapeutics Market Value Share (%), by Animal Type, 2025
- Figure 21: Europe Veterinary Therapeutics Market Value (USD billion), by Route of Administration, 2025 & 2034
- Figure 22: Europe Veterinary Therapeutics Market Value Share (%), by Route of Administration, 2025
- Figure 23: Europe Veterinary Therapeutics Market Value (USD billion), by Distribution Channel, 2025 & 2034
- Figure 24: Europe Veterinary Therapeutics Market Value Share (%), by Distribution Channel, 2025
- Figure 25: Europe Veterinary Therapeutics Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 26: Europe Veterinary Therapeutics Market Value Share (%), By Country/ Sub-region, 2025
- Figure 27: Asia Pacific Veterinary Therapeutics Market Value (USD billion), by Product, 2025 & 2034
- Figure 28: Asia Pacific Veterinary Therapeutics Market Value Share (%), by Product, 2025
- Figure 29: Asia Pacific Veterinary Therapeutics Market Value (USD billion), by Animal Type, 2025 & 2034
- Figure 30: Asia Pacific Veterinary Therapeutics Market Value Share (%), by Animal Type, 2025
- Figure 31: Asia Pacific Veterinary Therapeutics Market Value (USD billion),by Route of Administration, 2025 & 2034
- Figure 32: Asia Pacific Veterinary Therapeutics Market Value Share (%), by Route of Administration, 2025
- Figure 33: Asia Pacific Veterinary Therapeutics Market Value (USD billion), by Distribution Channel, 2025 & 2034
- Figure 34: Asia Pacific Veterinary Therapeutics Market Value Share (%), by Distribution Channel, 2025
- Figure 35: Asia Pacific Veterinary Therapeutics Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 36: Asia Pacific Veterinary Therapeutics Market Value Share (%), By Country/ Sub-region, 2025
- Figure 37: Latin America Veterinary Therapeutics Market Value (USD billion), by Product, 2025 & 2034
- Figure 38: Latin America Veterinary Therapeutics Market Value Share (%), by Product, 2025
- Figure 39: Latin America Veterinary Therapeutics Market Value (USD billion), by Animal Type, 2025 & 2034
- Figure 40: Latin America Veterinary Therapeutics Market Value Share (%), by Animal Type, 2025
- Figure 41: Latin America Veterinary Therapeutics Market Value (USD billion), by Route of Administration, 2025 & 2034
- Figure 42: Latin America Veterinary Therapeutics Market Value Share (%), by Route of Administration, 2025
- Figure 43: Latin America Veterinary Therapeutics Market Value (USD billion), by Distribution Channel, 2025 & 2034
- Figure 44: Latin America Veterinary Therapeutics Market Value Share (%), by Distribution Channel, 2025
- Figure 45: Latin America Veterinary Therapeutics Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 46: Latin America Veterinary Therapeutics Market Value Share (%), By Country/ Sub-region, 2025
- Figure 47: Middle East & Africa Veterinary Therapeutics Market Value (USD billion), by Product, 2025 & 2034
- Figure 48: Middle East & Africa Veterinary Therapeutics Market Value Share (%), by Product, 2025
- Figure 49: Middle East & Africa Veterinary Therapeutics Market Value (USD billion), by Animal Type, 2025 & 2034
- Figure 50: Middle East & Africa Veterinary Therapeutics Market Value Share (%), by Animal Type, 2025
- Figure 51: Middle East & Africa Veterinary Therapeutics Market Value (USD billion), by Route of Administration, 2025 & 2034
- Figure 52: Middle East & Africa Veterinary Therapeutics Market Value Share (%), by Route of Administration, 2025
- Figure 53: Middle East & Africa Veterinary Therapeutics Market Value (USD billion), by Distribution Channel, 2025 & 2034
- Figure 54: Middle East & Africa Veterinary Therapeutics Market Value Share (%), by Distribution Channel, 2025
- Figure 55: Middle East & Africa Veterinary Therapeutics Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 56: Middle East & Africa Veterinary Therapeutics Market Value Share (%), By Country/ Sub-region, 2025
Figure 57: Global Veterinary Therapeutics Market Share (%), By Company, 2025
